Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.90p
   
  • Change Today:
      0.050p
  • 52 Week High: 11.85p
  • 52 Week Low: 3.45p
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 0
  • Market Cap: £26.13m

Eden Research's 'Cedroz' gets authorisation in Spain

By Josh White

Date: Tuesday 01 Sep 2020

LONDON (ShareCast) - (Sharecast News) - Biopesticides company Eden Research announced on Tuesday that its commercial collaborator Eastman Chemical Company has received authorisation for the sale of 'Cedroz' in Spain.
The AIM-traded firm said the approval in Spain covered both glasshouse and open-field uses on tomatoes, cucumbers, zucchini, pumpkins, strawberries and melons, as well as glasshouse use on peppers and aubergine.

It was Eden's second product to be authorised in Spain, with the company selling the botryticide 'Araw' for several years.

Both Cedroz and Araw are based on terpene active ingredients, and encapsulated by Eden's patented 'Sustaine' technology.

"For various reasons, including the volume of fruit and vegetables produced and the size of the organic area, Spain represents an important market in the EU for Eden," said chief executive officer Sean Smith.

"The authorisation today presents a substantial opportunity to further address the Spanish market, with our existing terpene based bio-fungicide already being sold.

"The country is well known around the world for its horticultural produce and is a major exporter to a number of countries, including the UK, and we look forward to working with Eastman to grow our presence in the region."

At 0932 BST, shares in Eden Research were up 5.26% at 7p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Eden Research Market Data

Currency UK Pounds
Share Price 4.90p
Change Today 0.050p
% Change 1.03 %
52 Week High 11.85p
52 Week Low 3.45p
Volume 0
Shares Issued 533.35m
Market Cap £26.13m

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
21.24% below the market average21.24% below the market average21.24% below the market average21.24% below the market average21.24% below the market average
49.02% below the sector average49.02% below the sector average49.02% below the sector average49.02% below the sector average49.02% below the sector average
Price Trend
46.96% above the market average46.96% above the market average46.96% above the market average46.96% above the market average46.96% above the market average
70.37% above the sector average70.37% above the sector average70.37% above the sector average70.37% above the sector average70.37% above the sector average
Income Not Available
Growth
49.25% above the market average49.25% above the market average49.25% above the market average49.25% above the market average49.25% above the market average
47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average

Eden Research Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page